D-1435-2019 Class II Terminated
FDA drug recall D-1435-2019 was initiated by Baxter Healthcare Corporation on Jun 13, 2019 and is designated Class II. Reason for recall: Failed Stability Specifications The recall status is terminated (terminated Apr 29, 2020). Affected quantity: 5940 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 19, 2019
- Initiation Date
- Jun 13, 2019
- Termination Date
- Apr 29, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 5940 bottles
Product description
Sevoflurane, USP Inhalation Anesthetic 250 mL bottles, Rx only, Manufactured for Baxter Healthcare Corporation Deerfield, IL 60015 USA, NDC 10019-651-64
Reason for recall
Failed Stability Specifications
Distribution pattern
Nationwide within the United States
Code information
Lot #: S110F822 Exp. 5/31/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1435-2019
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026